CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-08 | Trizzino John SVP, CBO and CFO | Exercise or conversion · Restricted Stock Units | −468 | 0 | ||
| 2020-03-08 | Glenn Gregory M President, R&D | Exercise or conversion | +760 | 2,133 | ||
| 2020-03-08 | Glenn Gregory M President, R&D | Shares withheld for taxes | −294 | $12.48 | $4K | 1,839 |
| 2020-03-08 | Glenn Gregory M President, R&D | Exercise or conversion · Restricted Stock Units | −760 | 0 | ||
| 2020-03-08 | Erck Stanley C President and CEO | Exercise or conversion | +6,072 | 22,486 | ||
| 2020-03-08 | Erck Stanley C President and CEO | Shares withheld for taxes | −1,992 | $12.48 | $25K | 20,494 |
| 2020-03-08 | Erck Stanley C President and CEO | Exercise or conversion · Restricted Stock Units | −6,072 | 0 | ||
| 2020-01-31 | Glenn Gregory M President, R&D | Purchase | +1,250 | $3.86 | $5K | 1,373 |
| 2019-12-12 | YOUNG JAMES F Director | Grant or award · Stock Option (Right to buy) | +37,500 | 37,500 | ||
| 2019-12-12 | MCMANUS MICHAEL A JR Director | Grant or award · Stock Option (Right to buy) | +18,000 | 18,000 | ||
| 2019-12-12 | King Rachel K. Director | Grant or award · Stock Option (Right to buy) | +18,000 | 18,000 | ||
| 2019-09-26 | Glenn Gregory M President, R&D | Grant or award · Stock Appreciation Right | +66,100 | 66,100 | ||
| 2019-09-26 | Erck Stanley C President and CEO | Grant or award · Stock Appreciation Right | +100,000 | 100,000 | ||
| 2019-09-26 | Trizzino John EVP, CBO and CFO | Grant or award · Stock Appreciation Right | +18,400 | 18,400 |
Page 87 of 87 · 1,734 trades